These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Hering R; Petrovic S; Mietz EM; Holzmann C; Berg D; Bauer P; Woitalla D; Müller T; Berger K; Krüger R; Riess O Neurology; 2004 Apr; 62(7):1231-2. PubMed ID: 15079038 [No Abstract] [Full Text] [Related]
9. Identification and characterization of human NR4A2 polymorphisms in attention deficit hyperactivity disorder. Smith KM; Bauer L; Fischer M; Barkley R; Navia BA Am J Med Genet B Neuropsychiatr Genet; 2005 Feb; 133B(1):57-63. PubMed ID: 15635701 [TBL] [Abstract][Full Text] [Related]
10. NR4A2 genetic variation and Parkinson's disease: Evidence from a systematic review and meta-analysis. Liu H; Liu H; Li T; Cui J; Fu Y; Ren J; Sun X; Jiang P; Yu S; Li C Neurosci Lett; 2017 May; 650():25-32. PubMed ID: 28385514 [TBL] [Abstract][Full Text] [Related]
11. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Karamohamed S; Golbe LI; Mark MH; Lazzarini AM; Suchowersky O; Labelle N; Guttman M; Currie LJ; Wooten GF; Stacy M; Saint-Hilaire M; Feldman RG; Liu J; Shoemaker CM; Wilk JB; DeStefano AL; Latourelle JC; Xu G; Watts R; Growdon J; Lew M; Waters C; Vieregge P; Pramstaller PP; Klein C; Racette BA; Perlmutter JS; Parsian A; Singer C; Montgomery E; Baker K; Gusella JF; Herbert A; Myers RH Mov Disord; 2005 Sep; 20(9):1188-91. PubMed ID: 15966003 [TBL] [Abstract][Full Text] [Related]
12. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease. Grimes DA; Han F; Panisset M; Racacho L; Xiao F; Zou R; Westaff K; Bulman DE Mov Disord; 2006 Jul; 21(7):906-9. PubMed ID: 16532445 [TBL] [Abstract][Full Text] [Related]
13. Point mutations in exon 1 of the NR4A2 gene are not a major cause of familial Parkinson's disease. Zimprich A; Asmus F; Leitner P; Castro M; Bereznai B; Homann N; Ott E; Rutgers AW; Wieditz G; Trenkwalder C; Gasser T Neurogenetics; 2003 Aug; 4(4):219-20. PubMed ID: 12827450 [No Abstract] [Full Text] [Related]
14. Nurr1 mutational screen in Parkinson's disease. Tan EK; Chung H; Chandran VR; Tan C; Shen H; Yew K; Pavanni R; Puvan KA; Wong MC; Teoh ML; Yih Y; Zhao Y Mov Disord; 2004 Dec; 19(12):1503-5. PubMed ID: 15390059 [TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of NR4A2 gene in a large population of Han Chinese patients with Parkinson's disease. Liu H; Tao Q; Deng H; Ming M; Ding Y; Xu P; Chen S; Song Z; Le W Eur J Neurol; 2013 Mar; 20(3):584-587. PubMed ID: 22827504 [TBL] [Abstract][Full Text] [Related]
16. Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death. Jakaria M; Haque ME; Cho DY; Azam S; Kim IS; Choi DK Mol Neurobiol; 2019 Aug; 56(8):5799-5814. PubMed ID: 30684217 [TBL] [Abstract][Full Text] [Related]
17. Tyrosine hydroxylase gene regulation in human neuronal progenitor cells does not depend on Nurr1 as in the murine and rat systems. Jin H; Romano G; Marshall C; Donaldson AE; Suon S; Iacovitti L J Cell Physiol; 2006 Apr; 207(1):49-57. PubMed ID: 16252282 [TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers. Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529 [TBL] [Abstract][Full Text] [Related]
20. Expression and function of nr4a2, lmx1b, and pitx3 in zebrafish dopaminergic and noradrenergic neuronal development. Filippi A; Dürr K; Ryu S; Willaredt M; Holzschuh J; Driever W BMC Dev Biol; 2007 Dec; 7():135. PubMed ID: 18053265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]